| Primary |
| Product Used For Unknown Indication |
36.9% |
| Gait Disturbance |
31.4% |
| Multiple Sclerosis |
25.4% |
| Drug Use For Unknown Indication |
2.2% |
| Muscular Weakness |
0.6% |
| Hypertension |
0.5% |
| Relapsing-remitting Multiple Sclerosis |
0.4% |
| Balance Disorder |
0.3% |
| Depression |
0.3% |
| Pain |
0.3% |
| Secondary Progressive Multiple Sclerosis |
0.3% |
| Muscle Spasticity |
0.2% |
| Peroneal Nerve Palsy |
0.2% |
| Fatigue |
0.2% |
| Ms |
0.2% |
| Primary Progressive Multiple Sclerosis |
0.1% |
| Drug Use For Unknown Indication |
0.1% |
| Adrenoleukodystrophy |
0.1% |
| Breast Cancer |
0.1% |
| Immobile |
0.1% |
|
| Convulsion |
19.3% |
| Urinary Tract Infection |
13.1% |
| Multiple Sclerosis Relapse |
7.6% |
| Death |
6.9% |
| Tremor |
5.8% |
| Fall |
5.7% |
| Inappropriate Schedule Of Drug Administration |
4.3% |
| Abasia |
3.4% |
| Vomiting |
3.3% |
| Loss Of Consciousness |
3.2% |
| Gait Disturbance |
3.1% |
| Dizziness |
3.0% |
| Insomnia |
3.0% |
| Nausea |
3.0% |
| Drug Ineffective |
2.8% |
| Muscular Weakness |
2.8% |
| Paraesthesia |
2.6% |
| Therapeutic Response Unexpected |
2.4% |
| Grand Mal Convulsion |
2.3% |
| Pneumonia |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
40.1% |
| Multiple Sclerosis |
26.5% |
| Gait Disturbance |
17.0% |
| Depression |
3.4% |
| Hypertension |
1.6% |
| Muscle Spasticity |
1.6% |
| Pain |
1.6% |
| Muscle Spasms |
1.3% |
| Blood Cholesterol Increased |
0.9% |
| Tremor |
0.9% |
| Anxiety |
0.7% |
| Contraception |
0.5% |
| Neuropathy Peripheral |
0.5% |
| Relapsing-remitting Multiple Sclerosis |
0.5% |
| Thyroid Disorder |
0.5% |
| Urinary Tract Infection |
0.5% |
| Bladder Spasm |
0.4% |
| Blood Cholesterol |
0.4% |
| Drug Use For Unknown Indication |
0.4% |
| Fatigue |
0.4% |
|
| Convulsion |
10.8% |
| Urinary Tract Infection |
10.8% |
| Insomnia |
8.8% |
| Multiple Sclerosis Relapse |
7.4% |
| Muscular Weakness |
7.4% |
| Vomiting |
6.1% |
| Urticaria |
5.4% |
| Tremor |
4.7% |
| Headache |
4.1% |
| Renal Failure Acute |
4.1% |
| Urinary Incontinence |
4.1% |
| Inappropriate Schedule Of Drug Administration |
3.4% |
| Nausea |
3.4% |
| Rash |
3.4% |
| Breast Cancer Female |
2.7% |
| Drug Ineffective |
2.7% |
| Gait Disturbance |
2.7% |
| Hypoaesthesia |
2.7% |
| Pain |
2.7% |
| Palpitations |
2.7% |
|
| Concomitant |
| Multiple Sclerosis |
54.4% |
| Product Used For Unknown Indication |
21.4% |
| Gait Disturbance |
11.5% |
| Pain |
1.6% |
| Balance Disorder |
1.6% |
| Depression |
1.3% |
| Fatigue |
1.2% |
| Muscle Spasticity |
1.1% |
| Relapsing-remitting Multiple Sclerosis |
1.0% |
| Premedication |
0.8% |
| Muscle Spasms |
0.7% |
| Supplementation Therapy |
0.6% |
| Hypertension |
0.5% |
| Neuralgia |
0.5% |
| Anxiety |
0.4% |
| Medical Diet |
0.4% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Pain In Extremity |
0.3% |
| Constipation |
0.3% |
| Fall |
0.3% |
|
| Multiple Sclerosis Relapse |
9.6% |
| Urinary Tract Infection |
9.2% |
| Gait Disturbance |
9.0% |
| Fatigue |
6.8% |
| Multiple Sclerosis |
5.9% |
| Vomiting |
5.4% |
| Tremor |
5.3% |
| Nausea |
5.2% |
| Fall |
4.8% |
| Flushing |
4.1% |
| Drug Ineffective |
3.9% |
| Headache |
3.8% |
| Muscular Weakness |
3.8% |
| Asthenia |
3.7% |
| Mobility Decreased |
3.5% |
| Balance Disorder |
3.3% |
| Vision Blurred |
3.3% |
| Pain In Extremity |
3.2% |
| Paraesthesia |
3.1% |
| Influenza Like Illness |
3.0% |
|
| Interacting |
| Gait Disturbance |
40.0% |
| Multiple Sclerosis |
40.0% |
| Product Used For Unknown Indication |
20.0% |
|
| Drug Interaction |
25.0% |
| Limb Discomfort |
25.0% |
| Lower Limb Fracture |
25.0% |
| Urinary Retention |
25.0% |
|
